Total Payments
$287.17
2024 Payments
$42.29
Companies
8
Transactions
19
Medicare Patients
655
Medicare Billing
$164,615
Payment Breakdown by Category
Food & Beverage$287.17 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $287.17 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Indivior Inc. | $176.79 | 11 | $0 (2024) |
| AbbVie Inc. | $21.70 | 1 | $0 (2023) |
| Alkermes, Inc. | $19.30 | 1 | $0 (2024) |
| Axsome Therapeutics, Inc. | $18.88 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.17 | 1 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $11.16 | 2 | $0 (2017) |
| Vanda Pharmaceuticals Inc. | $10.78 | 1 | $0 (2017) |
| Allergan Inc. | $10.39 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $42.29 | 2 | Indivior Inc. ($22.99) |
| 2023 | $71.81 | 4 | Indivior Inc. ($31.23) |
| 2022 | $93.43 | 6 | Indivior Inc. ($75.26) |
| 2021 | $35.49 | 2 | Indivior Inc. ($35.49) |
| 2020 | $11.82 | 1 | Indivior Inc. ($11.82) |
| 2017 | $32.33 | 4 | Takeda Pharmaceuticals America, Inc. ($11.16) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: CNS | ||||||
| 05/16/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: BH | ||||||
| 11/22/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: BH | ||||||
| 08/03/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: BH | ||||||
| 07/12/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/15/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: BH | ||||||
| 09/29/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: BH | ||||||
| 09/01/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: BH | ||||||
| 07/14/2022 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: BH | ||||||
| 02/08/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: BH | ||||||
| 09/16/2021 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: BH | ||||||
| 06/29/2021 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: BH | ||||||
| 12/09/2020 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: BH | ||||||
| 10/25/2017 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: Schizophrenia | ||||||
| 10/11/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 07/12/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: Central Nervous System (CNS) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 157 | 651 | $91,680 | $40,302 |
| 2022 | 4 | 162 | 593 | $87,200 | $40,166 |
| 2021 | 5 | 180 | 673 | $97,450 | $47,602 |
| 2020 | 4 | 156 | 629 | $90,050 | $36,545 |
Total Patients
655
Total Services
2,546
Medicare Billing
$164,615
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 506 | $65,780 | $28,308 | 43.0% |
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 16 | 80 | $16,800 | $8,139 | 48.4% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 13 | 28 | $3,920 | $1,950 | 49.7% |
| 90832 | Psychotherapy, 30 minutes | Office | 2023 | 12 | 37 | $5,180 | $1,906 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 118 | 461 | $59,930 | $26,425 | 44.1% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 20 | 105 | $22,050 | $10,933 | 49.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 12 | 12 | $3,120 | $1,862 | 59.7% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 12 | 15 | $2,100 | $946.17 | 45.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 125 | 504 | $65,520 | $31,122 | 47.5% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 16 | 99 | $20,790 | $11,398 | 54.8% |
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 12 | 35 | $4,900 | $2,075 | 42.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 13 | 13 | $3,380 | $1,898 | 56.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 14 | 22 | $2,860 | $1,109 | 38.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 115 | 489 | $63,570 | $24,468 | 38.5% |
| 90837 | Psychotherapy, 60 minutes | Office | 2020 | 12 | 76 | $15,960 | $7,989 | 50.1% |
| 90832 | Psychotherapy, 30 minutes | Office | 2020 | 16 | 51 | $7,140 | $2,610 | 36.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 13 | 13 | $3,380 | $1,478 | 43.7% |
About Jane Broering Ammons, MD,
Jane Broering Ammons, MD, is a Psychiatry healthcare provider based in Maumee, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164596961.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jane Broering Ammons, MD, has received a total of $287.17 in payments from pharmaceutical and medical device companies, with $42.29 received in 2024. These payments were reported across 19 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($287.17).
As a Medicare-enrolled provider, Broering Ammons has provided services to 655 Medicare beneficiaries, totaling 2,546 services with total Medicare billing of $164,615. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Maumee, OH
- Active Since 11/20/2006
- Last Updated 08/20/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164596961
Products in Payments
- PERSERIS (Drug) $176.79
- VRAYLAR (Drug) $32.09
- ARISTADA (Drug) $19.30
- Auvelity (Drug) $18.88
- TRINTELLIX (Drug) $18.17
- Trintellix (Drug) $11.16
- Fanapt (Drug) $10.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.